Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627
This examiner grants 70% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18551699 | NOVEL CYCLOPENTA[C]PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B | Non-Final OA | Novartis AG |
| 17791110 | A METHOD OF TREATMENT IN PREDISPOSED SUBJECTS FOR LMNA-RELATED DILATED CARDIOMYOPATHY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18065348 | CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION | Non-Final OA | Massachusetts Institute of Technology |
| 17291055 | COMPOSITIONS AND METHODS USING A COMBINATION OF CURCUMIN AND AN OMEGA-3 FATTY ACID FOR CELLULAR ENERGY | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 16966263 | ANALGESIC AGENT AND SEDATIVE AGENT | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 18280531 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 17799638 | NOVEL TDZD ANALOGS AS AGENTS THAT DELAY, PREVENT, OR REVERSE AGE-ASSOCIATED DISEASES AND AS ANTI-CANCER AND ANTILEUKEMIC AGENTS | Non-Final OA | BIOVENTURES, LLC |
| 18282219 | POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF | Non-Final OA | Academia Sinica |
| 18269122 | SMALL MOLECULE DEGRADERS OF PHOSPHATIDYLINOSITOL-5-PHOSPHATE 4-KINASE TYPE 2 AND USES THEREOF | Non-Final OA | CORNELL UNIVERSITY |
| 18746815 | METHODS OF TREATMENT OR PREVENTION OF ACUTE BRAIN OR NERVE INJURIES | Non-Final OA | Annovis Bio, Inc. |
| 18566176 | SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE | Non-Final OA | VERTEX PHARMACEUTICALS INCORPORATED |
| 18328388 | Method and Composition for Treating Epilepsy | Final Rejection | Lipocine Inc. |
| 17604651 | ALKYL-TPP COMPOUNDS FOR MITOCHONDRIA TARGETING AND ANTI-CANCER TREATMENTS | Final Rejection | LUNELLA BIOTECH, INC. |
| 18325655 | R-MDMA CRYSTAL FORMS | Non-Final OA | Mind Medicine, Inc. |
| 18398201 | NITROGEN-CONTAINING POLYCYCLIC AROMATIC COMPOUND, and PREPARATION METHOD AND APPLICATION THEREOF | Non-Final OA | Hebei University of Science & Technology |
| 18561111 | PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTAL FORM THEREOF | Final Rejection | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. |
| 18566797 | PREPARATION OF A CHK1 INHIBITOR COMPOUND | Non-Final OA | PHARMAENGINE, INC. |
| 17770686 | USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUNDS FOR PREVENTION, ALLEVIATION, OR TREATMENT OF COGNITIVE DISORDERS, OR FOR IMPROVING COGNITIVE FUNCTION | Non-Final OA | SK BIOPHARMACEUTICALS CO., LTD. |
| 17769323 | COMPOUNDS FOR TARGETED DEGRADATION OF CARRIER PROTEINS AND USES THEREOF | Non-Final OA | CeMM - Forschungszentrum für Molekulare Medizin GmbH |
| 18289399 | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CEREBRAL INFARCTION | Non-Final OA | Corxel Pharmaceuticals Hong Kong Limited |
| 18289467 | MODULATORS OF TREX1 | Non-Final OA | Constellation Pharmaceuticals, Inc. |
| 18288455 | MODULATORS OF TREX1 | Non-Final OA | Constellation Pharmaceuticals, Inc. |
| 18498956 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | Non-Final OA | PETRA PHARMA CORPORATION |
| 18262459 | CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM | Non-Final OA | XIZANG HAISCO PHARMACEUTICAL CO., LTD. |
| 18552870 | HYALURONIC ACID-PRODUCTION PROMOTER | Final Rejection | NISSIN FOODS HOLDINGS CO., LTD. |
| 18371093 | Salts of Viloxazine | Non-Final OA | Apotex Inc. |
| 18255816 | Cannabidiol for the Treatment of Refractory Seizures | Non-Final OA | ZYNERBA PHARMACEUTICALS, INC. |
| 18273574 | Pharmaceutical Products Based on Cannabinoid Acid Esters | Non-Final OA | EVANGELOS DADIOTIS |
| 18272697 | AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL | Non-Final OA | The University of Liverpool |
| 18329491 | COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION | Non-Final OA | Xygenyx Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy